Business● LowOct 30 · Oct 30, 2026, 12:17 PM
AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan
GlobeAlert Desk · curated from EuroNews [en] · global
AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business1h agoAsian stock markets climb after earlier tech routAl Jazeera [en]Business3h agoChina’s inflation edges lower in OctoberFinancial TimesBusiness3h agoLow pay, fatigue and staff shortages put Hong Kong’s aviation hub status at risk: unionsSouth China Morning PostBusiness3h agoPHINMA | Daily Tribunetribune.net.ph · Philippines